Encompass Health reports results for fourth quarter 2022 and issues full-year 2023 guidance

Go back to Encompass Health reports results for fourth quarter 2022 and issues full-year 2023 guidance

Encompass Health Corporation (EHC) Tops Q4 EPS by 4c, Offers Guidance

February 7, 2023 4:41 PM EST

Encompass Health Corporation (NYSE: EHC) reported Q4 EPS of $0.88, $0.04 better than the analyst estimate of $0.84. Revenue for the quarter came in at $1.14 billion versus the consensus estimate of $1.12 billion.

GUIDANCE:

Encompass Health Corporation sees FY2023 EPS of $2.87-$3.16, versus the consensus... More